Fiche centre
Memorial Sloan-Kettering Cancer Center
New York — United States
Essais liés5clinical trials
VilleNew Yorklocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT00003595
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Filgrastim | SEP | Phase 3 | NCT00003595 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma | COMPLETED |
| WST 11 -mediated -VTP | Cancer | Phase 1/2 | NCT00946881 | Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer | COMPLETED |
| Exablate Prostate Treatment | Cancer | Non applicable | NCT03998657 | Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions | ACTIVE_NOT_RECRUITING |
| TRI-611 | Cancer | Phase 1/2 | NCT07491497 | A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC | RECRUITING |
| focal cryotherapy | Cancer | Phase 2 | NCT00774436 | Study of Focal Cryoablation in Low-Risk Prostate Cancer | COMPLETED |